89Zr-atezolizumab PET Scan and Lobular Breast Cancer
Stopped Cessation of main trial of which this study was a biomarker imaging side study.
Conditions
- Lobular Metastatic Breast Cancer
Interventions
- OTHER: 89Zr-atezolizumab PET scans
Sponsor
University Medical Center Groningen